Clinical Trial Detail

NCT ID NCT02163356
Title Fenretinide Lym-X-Sorb + Ketoconazole + Vincristine for Recurrent or Resistant Neuroblastoma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors South Plains Oncology Consortium
Indications

neuroblastoma

Therapies

Vincristine Sulfate

Fenretinide

Ketoconazole

Age Groups: adult child

No variant requirements are available.